Biotechnological preparations as a means of improving the safety of pharmacotherapy: state of the art and prospects of development

• Main Authors: A. A. Lidzhieva, E. A. Smolyarchuk, A. E. Kokorina, V. V. Smirnov, E. A. Egorenkov
• Format: Article
• Language: Russian
• Published: Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2018-02-01
• Series: Биопрепараты: Профилактика, диагностика, лечение
• Subjects: биосимиляры; биотехнологические препараты; биотехнология; инсулин; соматотропин; антибиотики; интерферон; моноклональные антитела; ферменты; biosimilar; biotech drugs; biotechnology; insulin; somatotropin; antibiotics; interferon; monoclonal antibodies; enzymes
• Online Access: https://www.biopreparations.ru/jour/article/view/57
• ISSN: 2221-996X; 2619-1156

Development and improvement of biotechnological drugs currently more relevant than ever. Drugs obtained by means of biotechnology, have a number of positive qualities. Biotechnology allows you to create such products, which are currently impossible to synthesize by chemical means, in addition, the production of drugs using biotechnology meets the standards of quality, efficacy and safety and, more importantly, economically. Biotech drugs are used for treatment of infectious, autoimmune, cancer, are used to prevent, thereby finding wide application in medicine.